Immunotherapy against metastatic bladder cancer by combined administration of granulocyte macrophage-colony stimulating factor and interleukin-2 surface modified MB49 bladder cancer stem cells vaccine

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Dendritic cell based immunotherapy using tumor stem cells mediates potent antitumor immune responses

(2016) Amir Dashti et al.   CANCER LETTERS

Cancer immunoprevention

(2016) Olivera J Finn et al.   CURRENT OPINION IN IMMUNOLOGY

Fusion cytokine IL-2-GMCSF enhances anticancer immune responses through promoting cell–cell interactions

(2016) Qian Wen et al.   Journal of Translational Medicine

Multiple-purpose immunotherapy for cancer

(2015) V.I. Seledtsov et al.   BIOMEDICINE & PHARMACOTHERAPY

Advances and perspectives of colorectal cancer stem cell vaccine

(2015) Mei Guo et al.   BIOMEDICINE & PHARMACOTHERAPY

Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy

(2015) Palash Bhattacharya et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity

(2015) Yaron Carmi et al.   NATURE

Development of a therapy against metastatic bladder cancer using an interleukin-2 surface-modified MB49 bladder cancer stem cells vaccine

(2015) Yong-tong Zhu et al.   Stem Cell Research & Therapy

Combination therapy with dendritic cell vaccine and IL-2 encapsulating polymeric micelles enhances intra-tumoral accumulation of antigen-specific CTLs

(2014) Kenji Miki et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

The granulocyte macrophage–colony stimulating factor surface modified MB49 bladder cancer stem cells vaccine against metastatic bladder cancer

(2014) Yong-tong Zhu et al.   Stem Cell Research

Therapeutic gene modified cell based cancer vaccines

(2013) Anna Kozłowska et al.   GENE

Cancer vaccines: Harnessing the potential of anti-tumor immunity

(2013) Mark A. Suckow   VETERINARY JOURNAL

A modified method for isolation of bladder cancer stem cells from a MB49 murine cell line

(2013) Yong-tong Zhu et al.   BMC Urology

Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity

(2012) S. Hong et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology

(2012) F. Abebe   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Cancer-Related Inflammation

(2012) Juliana Candido et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Prolonged circulation and in vivo efficacy of recombinant human granulocyte colony-stimulating factor encapsulated in polymeric micelles

(2011) Mitsunori Harada et al.   JOURNAL OF CONTROLLED RELEASE

Update on castrate-resistant prostate cancer: 2010

(2010) Kiran Lassi et al.   CURRENT OPINION IN ONCOLOGY

Involvement of ERK and JNK pathways in IFN-γ-induced B7-DC expression on tumor cells

(2010) Junfang Deng et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Vaccination with an Allogeneic Whole-Cell Melanoma Vaccine

(2009) M. B. Faries et al.   CLINICAL CANCER RESEARCH

Antigen-Specific T-Cell Response from Dendritic Cell Vaccination Using Cancer Stem-Like Cell-Associated Antigens

(2009) Qijin Xu et al.   STEM CELLS